Medgett I C, Ruffolo R R
Department of Pharmacology, Smith Kline and French Laboratories, King of Prussia, Pennsylvania.
J Pharmacol Exp Ther. 1988 Jul;246(1):249-54.
The alpha adrenoceptor subtypes mediating vasoconstriction to exogenous agonists and to spinal sympathetic nerve stimulation have been characterized in the autoperfused (constant flow) femoral (predominantly skeletal musculature) and saphenous (predominantly cutaneous) vascular beds of the pithed rat. Intra-arterial infusion of the alpha-1 adrenoceptor agonist, methoxamine, increased perfusion pressure in both vascular beds over the same range of infusion rates, and the maximum responses were similar. The selective alpha-2 adrenoceptor agonist, B-HT 933, also increased perfusion pressure in both beds, although the maximum response to B-HT 933 in the saphenous bed was approximately twice that observed in the femoral bed. Responses to methoxamine were blocked by the alpha-1 adrenoceptor antagonist, prazosin (0.1 mg/kg), but not the alpha-2 adrenoceptor antagonist, rauwolscine (1 mg/kg), or by the selective postjunctional alpha-2 adrenoceptor antagonist, SK&F 104078 (1 mg/kg). Conversely, responses to B-HT 933 were blocked by rauwolscine and by SK&F 104078, but not by prazosin. Vasopressor responses to B-HT 933 in both vascular beds of the rat hindlimb also were reduced markedly by the calcium channel blocker, nifedipine (1 mg/kg), whereas responses to methoxamine were relatively resistant to inhibition by nifedipine. In the femoral bed, as in the systemic arterial circulation, responses to sympathetic nerve stimulation were strongly inhibited by prazosin, were potentiated by rauwolscine and were unaffected by SK&F 104078. In contrast, in the saphenous arterial bed, the responses to sympathetic nerve stimulation were inhibited by all three antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)
在脊髓麻醉大鼠的自灌注(恒流)股动脉(主要为骨骼肌组织)和隐静脉(主要为皮肤)血管床中,已对介导对外源性激动剂和脊髓交感神经刺激产生血管收缩作用的α肾上腺素能受体亚型进行了表征。在相同的输注速率范围内,动脉内输注α1肾上腺素能受体激动剂甲氧明可使两个血管床的灌注压升高,且最大反应相似。选择性α2肾上腺素能受体激动剂B-HT 933也可使两个血管床的灌注压升高,尽管隐静脉床对B-HT 933的最大反应约为股动脉床的两倍。对甲氧明的反应可被α1肾上腺素能受体拮抗剂哌唑嗪(0.1mg/kg)阻断,但不能被α2肾上腺素能受体拮抗剂萝芙木碱(1mg/kg)或选择性接头后α2肾上腺素能受体拮抗剂SK&F 104078(1mg/kg)阻断。相反,对B-HT 933的反应可被萝芙木碱和SK&F 104078阻断,但不能被哌唑嗪阻断。大鼠后肢两个血管床对B-HT 933的升压反应也可被钙通道阻滞剂硝苯地平(1mg/kg)显著降低,而对甲氧明的反应对硝苯地平的抑制作用相对不敏感。在股动脉床,与全身动脉循环一样,对交感神经刺激的反应被哌唑嗪强烈抑制,被萝芙木碱增强,且不受SK&F 104078影响。相比之下,在隐静脉动脉床,对交感神经刺激的反应被所有三种拮抗剂抑制。(摘要截选至250词)